Erin S. LeBlanc, MD, MPH

Investigator
Photo of Erin LeBlanc

Dr. Erin LeBlanc is an epidemiologist and board-certified adult endocrinologist. Her research focuses on conditions that affect women, including menopause, obesity, osteoporosis, diabetes, and vitamin D deficiency.

In 2011, Dr. LeBlanc led a systematic evidence review on obesity to support the U.S. Preventive Services Task Force. In 2014, she will lead a systematic evidence review regarding screening for vitamin D. Currently, she is leading a study to examine risk factors associated with fractures among people taking bisphosphonates. The study is comparing people who suffered fractures during bisphosphonate therapy to people who did not, to identify characteristics that may differ.

Dr. LeBlanc is a co-investigator on the Study of Osteoporotic Fractures (SOF), a nearly 30-year-old study that is linking its database with Medicare claims data for nearly 10,000 women to examine relationships between aging and cognitive function, physical performance, bone mineral density, and body weight.

Dr. LeBlanc came to CHR in 2009 from Oregon Health & Science University (OHSU), where she proposed a randomized trial testing the efficacy of vitamin D repletion on body composition in perimenopausal women. She served as the Principal Investigator for the Women’s Health Initiative study, which examined heart disease, cancer, and osteoporosis in postmenopausal women.

Dr. LeBlanc graduated cum laude from the Yale University School of Medicine. Following her internal medicine residency at Stanford University and before joining OHSU, she completed a fellowship in women’s health at the Portland VA Medical Center. She is a member of the Endocrine Society and the American Diabetes Association. She remains an affiliate assistant professor of endocrinology at OHSU.

E-mail: Erin.S.LeBlanc@kpchr.org

Back to Investigators »

Recent Publications

Barbour KE, Lui-Yung L, Ensrud KE, Hiller TA, LeBlanc ES, Ing SW, Hochberg MC, Cauley JA; Sutdy of Osteoporotic Fractures (SOF) Research Group. Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res. 2014 Sep;29(9):2057-64. [Epub ahead of print]   PubMed abstract
Gourlay ML, Overman RA, Fine JP, Filteau BA, Ensrud KE, Crandall CJ, Gass ML, Johnson KC, LeBlanc ES, Robbins J, Womack CR, LaCroix AZ. Baseline age and time to major fracture in younger postmenopausal women. Menopause. 2014 Oct 27. [Epub ahead of print]   PubMed abstract
Leblanc ES, Desai M, Perrin N, Wactawski-Wende J, Manson JE, Cauley JA, Michael YL, Tang J, Womack C, Song Y, Johnson KC, O'Sullivan MJ, Woods N, Stefanick ML. Vitamin D levels and menopause-related symptoms. Menopause. 2014 Apr 14. [Epub ahead of print]   PubMed abstract
LeBlanc ES, Rosales AG, Balasubramanian A, O'Malley CD, Egbuna O, Friess D, Perrin NA. Risk factors for fracture among current, persistent users of bisphosphonates. Osteoporos Int. 2014 Oct 30. [Epub ahead of print]   PubMed abstract
Meyers KJ, Mares JA, Igo RP, Truitt B, Liu Z, Millen AE, Klein M, Johnson EJ, Engelman CD, Karki CK, Blodi B, Gehrs K, Tinker L, Wallace R, Robinson J, LeBlanc ES, Sarto G, Bernstein PS, SanGiovanni JP, Iyengar SK. Genetic evidence for role of carotenoids in age-related macular degreneration in the cartnoids in age-related eye disease study (CAREDS). Invest Ophthalmol Vis Sci. 2014 Jan 29;55(1):587-99. doi: 10.1167/iovs.13-13216. PMCID: PMC390880 [Available on 2014/7/1]   Full text
Ryckman KK, Rillamas-Sun E, Spracklen CN, Wallace RB, Garcia L, Tylavsky FA, Howard BV, Liu S, Song Y, Leblanc ES, White MV, Parikh NI, Robinson JG. Ethnic differences in the relationship between birth weight and type 2 diabetes mellitus in postmenopausal women. Diabetes Metab. 2014 Apr 18. pii: S1262-3636(14)00064-0. doi: 10.1016/j.diabet.2014.03.003. [Epub ahead of print]   PubMed abstract
Schnatz P, Jiang X, Vila-Wright S, Aragaki A, Nudy M, O'Sullivan D, Jackson R, LeBlanc E, Robinson J, Shikany JM, Womack C, Martin L, Neuhouser M, Vitolins M, Song Y, Kritchevsky S, Manson J. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause, 2014 Aug; 21(8):823-833. [Epub ahead of print]   PubMed abstract
Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, Igo RP Jr, Truitt B, Robinson J, Sarto GE, Wallace R, Blodi BA, Klein ML, Tinker L, LeBlanc ES, Jackson RD, Song Y, Manson JE, Mares JA, Millen AE. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. The Journal of Nutrition 2013 Jan; 143(1):17-26. [Epub 2012 Nov 28] PMCID: PMC3521459 [Available on 2014/1/1]   Full text
Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBlanc ES, Vaughan L, Robinson J, Rapp SR, Goveas JS, Lane D, Wactawski-Wende J, Stefanick ML, Li W, Resnick SM. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med 2013 Jun 24;1-8. [Epub 2013 Jun 24]   PubMed abstract
LeBlanc ES, Perrin N, Johnson JD Jr., Ballatore A, Hillier T. Over-the-counter and compounded vitamin D: Is potency what we expect? JAMA Internal Medicine 2013 Apr 8; 173(7):585-6.   PubMed abstract


More Publications »
Kaiser Permanente